Skip to main content
Premium Trial:

Request an Annual Quote

Orchid's CFO Resigns; Agilent Hires Bio-Rad Alumnus; Solexa Taps ABI Vet to Fill New VP Slot; Cellzome Names New CSO; and Others

NEW YORK (GenomeWeb News) - Agilent Technologies named Nick Roelofs as vice president and general manager of its life sciences solutions division, the company said Wednesday.
 
Previously, Roelofs was group operations officer for the life science group at Bio-Rad Laboratories. He also served as chief operating officer of Stratagene. He has held senior positions at Applied Biosystems and Baxter Diagnostic.

Orchid Cellmark senior vice president and chief financial officer Raymond Land resigned, the company said on Wenesday.
 
Land left Orchid after one year in the position.
 
The company is searching for a replacement, a spokesperson told GenomeWeb News. Instead of appointing an interim financial officer, Land's responsibilities have been temporarily distributed amongst other executives in the company.
 
Orchid Cellmark promised executive changes after reporting disappointing financial results for the first quarter.

Solexa named Richard Lussier to the newly created position of vice president of sales and field operations, the company said Wednesday.
 
He was president and general manager of Applied Biosystems Japan for five years and held other managerial positions in US, Japanese, and other Asian field organizations for ABI. He also managed the Asia-Pacific operations for Celera Genomics and held global field operations management positions with MJ Research, now part of Bio-Rad, and with Fluidigm.
 
Lussier received his MBA from Temple University and conducted postgraduate studies in molecular biology at the University of Vermont. He received a BS in biology and chemistry from Rhode Island College.

David Simmons joined Cellzome as chief scientific officer, the company said Wednesday.
 
For the past three years, Simmons was vice-president of inflammation discovery research at Wyeth Research and co-chair of the Inflammation Therapeutic Area Leadership team.

Before Wyeth, he was director of research at Celltech. He was a group director of neuroscience research at SmithKline Beecham Pharmaceuticals.

 
He began working at the University of Oxford as an independent postdoctoral research fellow. He became Wellcome Trust Senior Research Fellow at the Institute of Molecular Medicine, John Radcliffe Hospital.
 
Before Oxford, David was at the department of genetics at Harvard Medical School, and was a postdoctoral research fellow at the University of Edinburgh.

Norwegian life sciences company DiaGenic said yesterday it has appointed to its scientific advisory board three international Alzheimer's disease experts: Bengt Winblad, Khalid Iqbal, and Dag Aarsland.
 
Winblad is head of the Karolinska Institute's Alzheimer's Disease Research Centre in Stockholm, a member of the Nobel Assembly for the Prize of Medicine and Physiology, and chairman of the Medical Scientific Advisory Panel of the Alzheimer's Disease International.
 
Iqbal is professor and chairman of the department of neurochemistry at the New York State Institute for Basic Research. With Winblad, he co-founded the biennial International Conferences on Alzheimer's Disease & Related Disorders.
 
Aarsland is professor of geriatric psychiatry at the University of Bergen and the head of the Neuropsychiatric Institute in Stavanger, both in Norway.

The Indiana University School of Informatics at IU-Purdue University Indianapolis appointed Matthew Palakal as its associate dean for graduate studies and research on July 1, the university said Wednesday.
 
Palakal replaces Douglas Perry, who left to become the dean of the College of Informatics at Northern Kentucky University.
 
Palakal will continue to head the Informatics Research Institute. He originally came to IUPUI in 1988 as an assistant professor. He earned his bachelor's, master's, and doctorate degrees in computer science at Concordia University, Montreal, Canada.

Axela Biosensors named Paul Smith as vice-president of sales and marketing, the company said today. The appointment is effective immediately.
 
Previously, Smith was vice-president of sales in Europe and North America for Ciphergen Biosystems. Prior to that, he was a sales person with Beckman Coulter.
 
Smith earned a bachelor's degree in chemistry from Wilfrid Laurier University and continued his education in pharmacology at the University of Western Ontario.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.